Eden Innovations (ASX:EDE) secured $4.1 million through a strategic institution-led placement, marking a milestone in the company’s mission to scale its advanced technology portfolio.
The placement, which involved the issuance of 22.5 million fully paid ordinary shares, was executed at an issue price of $0.18 per share.
This price aligns with the company’s last traded price on the Australian Securities Exchange and represents a substantial 41% premium over the 15-day volume-weighted average price of approximately $0.13.
The capital raising effort was headlined by a cornerstone investment from the L1 Capital Global Opportunities Master Fund.
According to the company’s announcement, the freshly mobilised funds are earmarked to fast-track the commercialisation of EdenShield as it expands into high-stakes sectors, including defence, military applications, and critical infrastructure.
The capital will support the ongoing market penetration of the company’s established EdenCrete, OptiBlend, and Carbon Nanotube platforms, while providing essential working capital.
As an added incentive for participating investors, Eden will issue free-attaching options on a one-for-two basis, subject to shareholder approval.
The options are exercisable at $0.20 and carry an expiry date of Oct. 15.
At the time of reporting, Eden Innovations’ share price was $0.21.